27.3
Vivos Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
5.42
FY23:
2.46
FY24:
7.47
FY25:
4.38
(positive)
Change from FY21 to FY25
millions USD
FY21:
6.37
FY22:
8.30
FY23:
8.27
FY24:
7.81
FY25:
20.8
Total assets
Change from FY21 to FY25
millions USD
FY21:
33.7
FY22:
13.7
FY23:
10.7
FY24:
15.3
FY25:
25.2
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
7.51
FY22:
6.81
FY23:
7.29
FY24:
4.98
FY25:
18.1
(negative)
Change from FY21 to FY25
millions USD
FY21:
0.64
FY22:
2.11
FY23:
3.03
FY24:
2.35
FY25:
8.63
(positive)
Change from FY21 to FY25
millions USD
FY21:
25.5
FY22:
4.80
FY23:
0.41
FY24:
7.95
FY25:
−1.49
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
33.7
FY22:
13.7
FY23:
10.7
FY24:
15.3
FY25:
25.2
All amounts in millions USD